Page 26 - Michael Erman News Today

NEW YORK (Reuters) - Pfizer on Wednesday said the updated Pfizer-BioNTech COVID-19 vaccine expected to be used this fall elicited a strong antibody re...

Pfizer on Wednesday said the updated Pfizer-BioNTech COVID-19 vaccine expected to be used this fall elicited a strong antibody response against the highly mutated BA. subvariant of the coronavirus in a preclinical study in mice. The Centers for Disease Control and Prevention has previously indicated that BA.

SAINT Lucia continues to record COVID-19 cases despite a generally low testing rate, the Ministry of Health said this week...

A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from "Eris", a variant of the Omicron form of the coronavirus, rise around the country. Some public health experts hope that Americans will welcome the new shot as they would a flu jab. In the fall of 2022, by which time most people had either had the COVID virus or the vaccine, fewer than 50 million people got the shots.

COVID infections and hospitalizations are on the rise in the U.S., Europe and Asia. Health officials are pointing at the EG.5 Eris coronavirus, a subvariant of the Omicron lineage that originally... -Today at 06:11 am- MarketScreener

By Michael Erman NEW YORK (Reuters) - A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly receive...

By Michael Erman NEW YORK (Reuters) - A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly receive...

By Michael Erman NEW YORK (Reuters) - A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly receive...

By Michael Erman NEW YORK (Reuters) - A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly receive...

By Michael Erman NEW YORK (Reuters) - A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly receive...